Archive for November, 2018

$TGODF Building New Capacity upon First Commercial Cannabis Crop

  • Full-scale cannabis legalization in Canada in October led to a rush of consumer interest and a resultant shortage of supply as the new industry adapts
  • The Green Organic Dutchman is improving on its initial commercial crop by building facilities with 195,000 kilograms of annual production capacity
  • The company’s reach includes cultivation facilities in Canada and Jamaica, with additional hemp production in Poland
  • Vast distribution capabilities spread wide across Canada, Jamaica, Mexico and Europe

Soaring demand for legal cannabis products has strengthened the long-term outlook for cannabis cultivator The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), which is expanding its production capability as well as its international footprint in a bid to stay abreast of the market’s sweeping tide.

Canada’s nationwide legalization of cannabis in October opened the doors to a huge buying spree by consumers, even as its newly regulated industry struggled to cross the bar into the unknown expanse of legitimate high-quality marijuana production while the black market outlets that the legal industry threatened to extinguish continued to snap up customers unwilling to wait for the new market’s wheels to turn (http://nnw.fm/acNI8).

Legal cannabis retail outlets in Quebec, Manitoba, New Brunswick, British Columbia, Alberta, Nova Scotia and Saskatchewan reported supply shortages in late November, and Khurram Malik, CEO of diversified cannabis company Biome Grow, predicted that supply might only be adequate to meet demand by 2020 or later, according to the Motley Fool (http://nnw.fm/b47rS).

At the forefront of authorized producers, The Green Organic Dutchman dedicated its first commercial crop to a closed “Grower’s Circle” group of patients and investors as a show of loyalty to “those who supported TGOD and those who are most in need of medical cannabis therapy,” according to its third-quarter operations report. At the same time, the company was working to expand its existing 27,000 square feet of production space in Hamilton, Ontario, into an operation that’s expected to ramp-up to nearly 200,000 kilograms of annual capacity across Ontario, Quebec and Jamaica when construction is completed early next year, as well as scalable hemp capacity in Poland.

The company is improving efficiency measures in its existing commercial cultivation while developing five new strains for the medical and recreational markets amid the race to provide patients and other consumers with consistent, premium product.

The Motley Fool report notes the declining stock values of many cannabis producers following Canada’s transition to legalization, adding that investors may become increasingly unhappy if losses increase while growers continue expanding their capacity and working on product diversification, branding and marketing. That includes The Green Organic Dutchman, which the report describes as a potential top-five producer once it gets running on all cylinders with its expected 195,000 kilograms of annual production (including 40,000 kilogram-equivalents from edibles and cannabis-infused beverages as they become legal).

The Green Organic Dutchman acknowledged in its third quarter report that “expanding its operations, administration and marketing infrastructure to rapidly scale its business” resulted in a loss for the three and nine months ended September 30, but it stated that those losses were in line with budgeted expectations.

Chief Financial Officer Sean Bovingdon noted in the third quarter report that The Green Organic Dutchman “has secured its financial future by raising over $450 million [and] fully funding [the company’s] current domestic and international plans,” adding that TGOD has “no plans to return to the market for additional capital at this time.”

Bovingdon continued, “We have de-risked the capital side of our business and with our focus now on delivering medical and recreational sales in Canada and internationally. We expect to drive significant value for shareholders in 2019 and beyond.”

For more information, visit the company’s website at www.TGOD.ca

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, November 30th, 2018 Uncategorized Comments Off on $TGODF Building New Capacity upon First Commercial Cannabis Crop

$NUGL Returns to Money TV

LOS ANGELES, CA, Nov. 30, 2018 — via NEWMEDIAWIRE — NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry’s new standard of technology, is pleased to announce its second interview on the venerable financial program, Money TV.

“We had to get back on the air and let the investing public know what we’ve been up to beyond the confines of a press release,” said Ryan Bartette, Chief Marketing Officer, NUGL.  “We now have launched our much-anticipated advertising platform with full reporting analytics 25 days ahead of schedule and even improved the imperative search function.  Our users already love it and we are selling new ads daily, monetizing our ever-growing user traffic.

“For the next few weeks we plan on using the Money TV format to update our current and prospective shareholders on all the roll-outs, development and general progress at NUGL,” added Bartlette.

Stay tuned to the latest NUGL appearances on Money TV at the link below:

http://moneytv.net/this-weeks-show/

About NUGL

NUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

For more information and updates, visit one of the links below.

Website: http://www.nugl.com/
Facebook:  https://www.facebook.com/nuglapp/
Instagram: https://www.instagram.com/nuglapp/
Twitter: https://twitter.com/nuglapp/

LinkedIn: https://www.linkedin.com/company/nuglapp/

Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: “plans”, “anticipates,” “expects,” “believes” or similar words of like kind. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in the company’s business plan and filings with the OTC Markets Group.

Contact Information:

Website: www.nugl.com 

Email: info@nugl.com 

Phone: (714) 383-9982

Investor Relations & Financial Media

info@integrityir.com

Toll Free: (888) 216-3595

www.IntegrityIR.com
Friday, November 30th, 2018 Uncategorized Comments Off on $NUGL Returns to Money TV

$VVCIF Reports Record Revenue for Q3 2018

  • Revenue of $2.3 million
  • Pro-Forma Revenue of $4.4 million

NAPANEE, Ontario, Nov. 30, 2018 — VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, ABcann Medicinals Inc. (“ABcann”) and Canna Farms Limited (“Canna Farms”), is pleased to announce the release of its financial results for the three and nine months ended September 30, 2018. The results represent the Company’s strongest financial performance to date.

“The acquisition of Canna Farms represents a transformational transaction in the evolution of VIVO that has led to a record quarter of $2.3 million revenue, with $4.4 million of pro forma revenue for the full quarter. Not only has this acquisition provided a significant revenue impact, it has tripled our production capacity, expanded our product range and substantially increased our medical patient base,” stated Barry Fishman, CEO of VIVO.

Q3 2018 Highlights

  • Q3 revenue of $2.3 million
  • Completion of the acquisition of Canna Farms on August 31, 2018, resulting in pro forma Q3 revenue of $4.4 million (the revenue that VIVO would have reported had Canna Farms been owned for the entire quarter)
  • At the end of Q3 2018, total medical cannabis patients of 18,000 compared to 2,000 at the end of Q2 2018 (representing a 9-fold increase)
  • Entry into adult-use supply agreements with British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and the Yukon, and Canna Farms achieving one of the best order fulfillment rates in the industry
  • Beacon Medical™ product was introduced into the Australian market
  • The upgrading of the Company’s common shares to the OTCQX® Best Market in the United States
  • Completion of corporate re-branding, including name change to VIVO Cannabis and the launch of the Beacon Medical™ cannabis brand
  • Introduction of the Lumina™ and Fireside™ adult-use cannabis brands
  • Expansion of senior level management team and appointment of Daniel Laflamme to the Company’s board of directors.

Highlights Subsequent to Q3 2018

  • The launch of Harvest Medicine’s HMED Connect telemedicine app, which allows patients across Canada to access Harvest Medicine’s class-leading education and patient-centric model at any time, and is expected to create significant partnership opportunities with pharmacies, long-term care facilities and insurance companies
  • Acquisition of Trauma Healing Centres (“THC”), a leading east coast chain of medical cannabis clinics, resulting in Harvest Medicine and THC currently operating six clinic locations across four provinces representing a total of 22,000 active patients
  • Strategic equity investments in Canadian cannabis retailers, National Access Cannabis Corp. and Westleaf Cannabis Inc.
  • VIVO’s capacity to supply both the medical and adult-use markets will be enhanced in the first half of 2019 with internal expansion in BC and Ontario and through certified third-party partner supply agreements.

Financial Results

VIVO reported revenues of $2.3 million and a net loss of $9.1 million for the third quarter of 2018, as the Company continues to invest to drive future growth. Non-recurring advertising and promotion expenses incurred in preparation for the launch of the adult-use market on October 17, 2018 and expenses related to the Canna Farms acquisition were a material factor in the increase in net loss.

As at September 30, 2018, the Company had $100 million in cash, cash equivalents and short-term investments, total assets of $285 million, total liabilities of $61 million, and 291 million common shares outstanding.

Key Financial Metrics
(in millions)
Three Months Ended September 30
Nine Months Ended September 30
2018
($)
2017
($)
2018
($)
2017
($)
Sales 2.3 0.2 3.9 0.6
Adjusted EBITDA(1) (4.7) (3.7) (11.6) (7.9)
Cash and short-term investments 100.4 43.4 100.4 43.4
 (1) Adjusted EBITDA is not a measure of financial performance under IFRS. The definition for Adjusted EBITDA can be found in the Company’s management discussion and analysis for the period ended September 30, 2018 at www.sedar.com.

Additional details with respect to the Company’s results of operations are available in its management’s discussion and analysis and condensed interim consolidated financial statements for the period ended September 30, 2018, both of which can be found on SEDAR at www.sedar.com.

Strategic Agreements

Since June 30, 2018, the Company has entered into a number of agreements that will provide a strong platform for future growth, including:

  • an agreement with Pharmascience Inc., a global pharmaceutical company based in Montreal that is a Licensed Dealer, to develop a line of specific medical cannabis formulations on behalf of the Company that are intended to maximize therapeutic benefit to patients by using pharmaceutical quality and precise dosing standards
  • an applied research agreement with Loyalist College’s Applied Research Centre for Natural Products and Medical Cannabis (ARC) to investigate and develop innovative processes for the extraction and formulation of cannabis oils
  • an agreement between Harvest Medicine and Think Research, a leading digital healthcare platform provider, to enhance its national medical cannabis care and education platform
  • a multi-year agreement with national cannabis distributor, Green Hedge Education & Distribution Services Ltd., to provide sales and distribution services to licensed cannabis wholesalers and retailers across Canada.

About VIVO Cannabis™

VIVO is recognized for trusted, high-quality products and services. Through Canna Farms and ABcann Medicinals, it holds production and sales licences for cannabis and cannabis oils from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia, in August 2018. Canna Farms was BC’s first Licensed Producer and has several years of craft cultivation experience and expertise.

The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. In the fourth quarter of 2018, VIVO also acquired THC, which was subsequently amalgamated with Harvest Medicine. Harvest Medicine and THC operate a patient-centric and highly scalable network of specialty medical cannabis clinics in Alberta and on the east coast of Canada, as well as HMED Connect, a free telemedicine service.

VIVO has a healthy balance sheet and is well-positioned to accelerate the growth of its business, in Canada and internationally.

More Information
Barry Fishman, CEO: barry.fishman@vivocannabis.com
Michael Bumby, CFO: michael.bumby@vivocannabis.com
Website: vivocannabis.com


ON BEHALF OF THE BOARD OF DIRECTORS

Barry Fishman (CEO and Director)

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

All dollar amounts in this news release are in Canadian dollars. Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements relating to the Company’s plans to expand production capacity and pursue partnership and product development opportunities domestically and internationally. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: (i) that the Company may not be able to achieve its production capacity targets at some or all of its production facilities; (ii) that the Company may not be able to launch new products in the time expected or at all; (iii) that the Company may not be able to achieve competitive margins; (iv) that the Company may not be able to increase the sales of its products in the current domestic market or to successfully launch new product lines in the time expected or at all; (v) that new products, if launched, may not be accepted by the market or may become subject to product liability claims; (vi) that the Company may not be able to obtain a distribution/import license or a cultivation license for Germany or other emerging markets it is targeting; (vii) that the Company may not be able to serve larger and broader markets as a result of its production increase; (viii) that the Company may be unable to retain its key talent; and (ix) other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company’s annual information form dated April 30, 2018, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

 

Friday, November 30th, 2018 Uncategorized Comments Off on $VVCIF Reports Record Revenue for Q3 2018

$YGYI to Present at the 11th Annual LD Micro Main Event

SAN DIEGO, Nov. 29, 2018  — Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that its President and Chief Financial Officer, Dave Briskie, will present at the 11th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Youngevity is scheduled to present on Wed., Dec. 5, 2018, at 2:00 p.m. PST.  Youngevity will also attend one-on-one meetings with institutional investors throughout the day.

The Youngevity presentation will be webcast and can be followed at http://wsw.com/webcast/ldmicro15/ygyi/. The webcast will be available on Youngevity’s website, YGYI.com, for thirty days.

The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 companies presenting to an audience of over 1,200 attendees.

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI ), is a leading omni-direct lifestyle company — offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, and photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event). In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue our international growth, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability  to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance, and the other factors discussed in our Annual Report on Form 10-K and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

 

Thursday, November 29th, 2018 Uncategorized Comments Off on $YGYI to Present at the 11th Annual LD Micro Main Event

$TGODF Cannabis Global Growth Influencing Rapid Expansion

Palm Beach, FL – (November 29, 2018) — As the cannabis market continues to evolve and experiencing a compounding rate of growth due to factors such as legalization, product advancements and rising consumer interest, cannabis companies are heavily investing in the expansion of operations. Through high levels of private investment, operations within cannabis are expanding as leaders aim for lower costs with higher volumes of output. With millions invested in operations and process optimization, enhanced levels of growth are expected to continue in the multi-billion dollar market. Active cannabis stocks in the markets today include:  CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), Namaste Technologies Inc. (TSX-V:N) (OTC:NXTTF), Neptune Wellness Solutions Inc. (NASDAQ:NEPT) (TSX:NEPT), HEXO Corp. (TSX:HEXO) (OTC:HYYDF).

CROP Infrastructure Corp. (CSE:CROP) (OTCPK:CRXPF) BREAKING NEWS:  CROP Infrastructure  announced today it has signed a toll processing agreement with a manufacturing company that will produce oils, crumbles and distillates for sale in to the California market.

The raw material will be finished cannabis from CROP’s Humboldt County farm where the cannabis is awaiting sale, being trimmed or drying. The farm is currently flowering 10,000 sqft of canopy for a late stage harvest and is working on the permitting for its 2019 expansion including a proposed 30,000 sq ft automated greenhouse facility.

In addition, a distribution agreement is now in place for the cannabis which will be sold under the company’s Hempire brand for estimated gross revenue of approximately $1,600 per pound of flower. The farm has allocated 750lbs of inventory to be sold under the Hempire brand.

The distributor has offices in Oakland and Orange County. Their distribution network consists of approximately 350 licensed |cannabis stores across California.

CROP CEO, Michael Yorke, stated: “Progress is continuing on becoming fully vertically integrated with self-serving Emerald Heights retail application. Processing and distribution are key agreements in getting our product onto hundreds of potential retail shelves. CROP’s core goal is maximizing its return on investment from tenant 2018 production, while preparing and building relationships for an exciting 2019.”  Read this full announcement and more news for CROP Infrastructure at:    https://www.financialnewsmedia.com/news-crop/

Additional cannabis industry related developments from around the markets:

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) recently announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada. Velvet is a new company with distinct ownership created by the largest wine distributor in Canada, Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

Namaste Technologies Inc. (TSX-V:N.V) (OTCQB:NXTTF) recently announced that its wholly-owned subsidiary, Cannmart Inc. (“Cannmart”) has signed a Delivery Agreement (the “Agreement”) to launch much-anticipated same-day delivery service in the Greater Toronto Area (“GTA”) through Pineapple Express Delivery Inc. (“Pineapple Express”) for its medical cannabis products. Effective immediately, Cannmart patients within the GTA area will have access to same-day, set-time, and rushed delivery services. The launch of same-day delivery within Cannmart’s platform further supports the Company’s vision to offer value to its patients in a medical cannabis online marketplace.

Neptune Wellness Solutions Inc. (NASDAQ:NEPT) (TSX:NEPT) recently announced On Thursday, December 6, 2018 , management will present at the LD Micro Main Event XI in Los Angeles, CA , at 9:00 a.m. PST and be available to meet with investors attending the conference that day. A webcast of the presentation session and a copy of the company’s latest investor presentation will be available on the company’s website at https://neptunecorp.com/en/investors/events-and-presentations/.

HEXO Corp. (TSX:HEXO.TO) (OTCPK:HYYDF) recently announced  the closing of the acquisition of its interest in a large facility in Belleville, Ontario. This is the first facility that the Company has established outside of Quebec, further delivering on its national expansion strategy and allowing HEXO to create a centre of excellence for the development of advanced cannabis products. “Closing the transaction and acquiring our interest in this facility is integral to carrying out our hub and spoke business strategy,” said Sebastien St-Louis, HEXO’s CEO and co-founder. “The space can be scaled up based on our future needs and provides HEXO with the infrastructure it needs to continue partnering with Fortune 500 companies and to create category-winning cosmetics, edibles, vapes and more.” The centralized location, conveniently located along primary shipping routes in Ontario, will allow HEXO to process and distribute cannabis-based products to fulfil its commitments across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press release issued above by CROP Infrastructure Corp. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Thursday, November 29th, 2018 Uncategorized Comments Off on $TGODF Cannabis Global Growth Influencing Rapid Expansion

$SNNVF Releases Q3 2018 Financial Results, Reports Strong Revenue Growth

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) released financial and operational results for the three and nine months ended September 30, 2018. The Q3 2018 update (with figures reported in Canadian dollars unless otherwise stated) includes the following highlights: Revenue of $3.8 million with gross margin of 56 percent; year to date revenue of $13.4 million, up more than 30 percent year over year; initial operations and revenue from the extraction facility; closed $23 million bought deal financing.

“We continue to make progress towards completion of Phase 1, the first 325,000 square feet, of our purpose built, high-technology cannabis greenhouse in Cathedral City, California” Sunniva CEO Anthony Holler stated in the news release. “While we have remained committed to advancing our operations in order to play a leadership role in the California cannabis market as we launch our first Sunniva branded products in the first quarter of 2019, we have maintained solid performance of our existing operations with $3.8 million in revenue and gross margins of 56 percent in the third quarter. We have now generated year to date revenue of $13.4 million, a 30 percent increase over this same period last year.”

To view the full press release, visit: http://nnw.fm/ceS5B

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Its ability to leverage large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through its strategically positioned cultivation and extraction facilities, Sunniva intends to launch a suite of branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, and extracts while expanding upstream opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, November 29th, 2018 Uncategorized Comments Off on $SNNVF Releases Q3 2018 Financial Results, Reports Strong Revenue Growth

$NUGS Establishes Landmark Partnership in Cannabis Compliance Matters

LOS ANGELES, Nov. 29, 2018 — Cannabis Strategic Ventures, Inc. (OTC: NUGS) announced a partnership with Feldmann Nagel Cantafio Margulis, PLLC a boutique lawfirm formed in early 2004 by Charles Feldmann and David Nagel, with deep cannabis compliance expertise throughout the United States, Israel, and the international cannabis marketplace. As an extension of the Cannabis Strategic Ventures Team, Charles E. Feldmann, Founding Partner, will lead the legal team on matters related to cannabis enforcement, licensing, federal risk mitigation and compliance related issues at the local, state, national and international level.

Attorney Charles Feldmann was a former federal prosecutor and defense attorney in the United States Marine Corps and a former states narcotics prosecutor in Colorado. He previously served as a Drug Enforcement Agency (DEA) Drug Task Force Commander and is a former lecturer and instructor with the Department of Defense and with the National College of District Attorneys. Feldmann oversees the firm’s international cannabis practice and its military justice international division.

“Cannabis Strategic Ventures is proud to partner with Charles Feldmann and the Feldmann Nagel Cantafio Margulis team for all cannabis compliance related to cultivation, distribution, retail matters for our brands,” said Simon Yu, CEO, Cannabis Strategic Ventures. “The ever-evolving regulatory landscape at the state and national levels, and the increasing number of countries implementing cannabis-friendly legislations, makes it became critically important to have reputable experts on cannabis enforcement, licensing, federal risk mitigation on our team.”

Charles Feldmann stated, “Our law firm looks forward to being a strategic advisor and counselor to Cannabis Strategic Ventures, a publicly traded cannabis corporation, and providing their exceptional team with diverse legal and business expertise.”

Cannabis Strategic Ventures is committed to building category leaders within the cannabis and CBD space. A recent Grandview Research Report states that the global legal marijuana market is expected to reach USD 146.4 billion by the end of 2025 as legal marijuana continues to gain traction worldwide due to very high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. This week, South Korea legalized medical cannabis, laying the foundation for reform in Southeast Asia.

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.

About Feldmann Nagel Cantafio Margulis, PLLC
Feldmann Nagel Cantafio Margulis has a reputation for achieving exceptional results for clients in a variety of practices around the world. The firm was formed in early 2004 by Charles Feldmann and David Nagel. Charles Feldmann’s roots stem from his training as a JAG prosecutor and defense attorney with the United States Marine Corps and then his transition into state and federal governmental practice as a drug task force commander with the DEA and a local state deputy district attorney. The firm’s attorneys are committed to providing exceptional legal services to their clients and have earned distinctions from a number of professional organizations, including Martindale-Hubbell® and Super Lawyers® Magazine.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: ir@cannabisstrategic.com
Website: http://www.cannabisstrategic.com

Thursday, November 29th, 2018 Uncategorized Comments Off on $NUGS Establishes Landmark Partnership in Cannabis Compliance Matters

$PBIO Capitalizing on Ultra Shear Technology, Including in CBD Oil

Interviewing with Proactive Investors, CEO Richard T. Schumacher Also Highlights and Accentuates Importance of Timely Appointment of Dr. Brad Young as Chief Commercial Officer

SOUTH EASTON, MA / November 28, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that Richard T. Schumacher, President and CEO, was interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London.

Ultra Shear Technology (“UST”), the Company’s proprietary processing method, uniquely combines ultra high pressure with intense shearing forces to potentially create a wide range of high value product innovations for multiple major consumer and industrial markets. During the interview, Mr. Schumacher discussed the two major milestones recently achieved by the Company in its accelerated UST development program. While doing so, he described how the Company recently completed the development of the first working prototype of the UST system and had subsequently used this prototype system to demonstrate a unique and profound capability for making high value oil-based materials dissolve in water. Mr. Schumacher expanded on the Company’s vision for applying this ability to make oils soluble in water, which he believed would allow the Company to enter or serve multiple large and growing markets, including food and beverages, pharmaceuticals, nutraceuticals, and cosmetics.

Responding to Ms. Corrado’s questions, Mr. Schumacher stated that the Company had selected an initial focus for these efforts on the rapidly-growing CBD Oil market, estimated by the Brightfield Group to grow to about $22 billion by 2022. Mr. Schumacher pointed out that water soluble CBD could potentially solve several critical issues currently throttling development of this market, including the need to significantly increase the efficiency of CBD absorption by the body, the need to decrease the cost of CBD production per use, and the need to produce high quality, water soluble CBD with minimized quantities of added chemicals. Mr. Schumacher then discussed why he believes PBI’s proprietary UST platform could successfully meet these requirements.

Mr. Schumacher also devoted considerable attention to discussing the recent addition of the Company’s new Chief Commercial Officer, Dr. Bradford A. Young, including an overview of Dr. Young’s blend of scientific and business education and leadership experience. Mr. Schumacher underlined his excitement for the contribution he anticipated from Dr. Young in developing and implementing a new commercialization strategy for the Company that could successfully drive product adoption and accelerate revenue growth. Mr. Schumacher concluded by noting that Dr. Young and he had begun to explore potential opportunities in the CBD space and that they had received strong interest from several groups with whom they had spoken.

Jeffrey N. Peterson, PBI’s Board Chairman , stated: “We are very pleased to have had the opportunity to share the Company’s recent milestones with a rapidly expanding, worldwide audience of potential investors, partners, customers, and collaborators. Proactive Investors is a well-respected, far-reaching multi-media news organization with the ability to effectively broadcast the corporate stories investors need to hear. We appreciated the insightful interview opportunity with Christine Corrado and we hope that many of their viewers will have the opportunity to watch this milestone interview. Ric Schumacher does an excellent job of explaining the expected impact of our powerful new UST platform, in conveying our excitement for the potential of this proprietary system to be a game-changer in the CBD/cannabinoids and other marketplaces, and in discussing the potential impact that the UST platform could have on our future revenue and growth.”

Click here to access the video interview.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President and CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman of the Board (650) 812-8121 (T)

Wednesday, November 28th, 2018 Uncategorized Comments Off on $PBIO Capitalizing on Ultra Shear Technology, Including in CBD Oil

$PFSF Aims to Streamline Trade Between Brazil and China

Pacific Software (OTC: PFSF) is currently developing a proprietary multi-lingual ecommerce B2B and B2C trade platform. The platform, anticipated to be released by the end of the year, is intended to ease trade between exporters in Brazil and importers in China. A recent article discussing the company reads, “Pacific Software is touting the benefits of its blockchain trade platform in smoothing the passage of Brazil’s substantial beef exports to China (mostly Hong Kong), presently running at a rate of about $5 billion per annum. The platform will improve transparency and trust with regard to origin, product quality and product safety and allow food contamination to be more easily detected by tracing the exact source. This will reduce costs tremendously. Under present systems, large quantities of both good food and bad are recalled and destroyed, because it is difficult to pinpoint the precise origin of an outbreak of Escherichia coli (E. coli), Salmonella enteritidis or some other contaminant. In addition, it could save lives. Every year, around 420,000 people die due to food contaminated by bacteria, chemicals, viruses, parasites and toxins.”

To view the full article, visit: http://nnw.fm/Ka9o3

About Pacific Software

Pacific Software, Inc. (OTC: PFSF) is an emerging development technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms.  The Company is a designer, developer and commercial distributor of blockchain-based systems.  The Company intends to be uniquely positioned to deliver B2B and B2C blockchain solutions by utilizing IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure for two key industries: Agriculture, to target farm-to-table beef exports; and Opioids/Controlled Substance Management, to create a verifiable and trusted ledger between pharmaceutical manufacturers and consumers.  For additional information please visit www.PacificSoftwareInc.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, November 28th, 2018 Uncategorized Comments Off on $PFSF Aims to Streamline Trade Between Brazil and China

$SNNVF Q3 2018 Financial Results, Strategic Update on Canadian Operations

Third Quarter Highlights 

  • Revenue of $3.8 million with gross margin of 56%
  • Year to date revenue of $13.4 million, up over 30% year over year
  • Initial operations and revenue from the Extraction Facility (as defined below)
  • Closed $23 million bought deal financing (the “Offering”)

VANCOUVER, British Columbia, Nov. 28, 2018 – Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, today released its financial and operational results and management’s discussion and analysis for the three and nine months for the third quarter of 2018 ended September 30, 2018. All figures are reported in Canadian dollars ($) unless otherwise stated. Sunniva’s financial statements are prepared in accordance with International Financial Reporting Standards.

“We continue to make progress towards completion of Phase 1, the first 325,000 square feet, of our purpose built, high-technology cannabis greenhouse in Cathedral City, California.  While we have remained committed to advancing our operations in order to play a leadership role in the California cannabis market as we launch our first Sunniva branded products in the first quarter of 2019, we have maintained solid performance of our existing operations with $3.8 million in revenue and gross margins of 56% in the third quarter.  We have now generated year to date revenue of $13.4 million, a 30 percent increase over this same period last year,” said Anthony Holler, Chief Executive Officer of Sunniva.

“With our strategic assets in place in California, we are now in a position to accelerate our revenue growth by advancing upon our upstream vertical opportunities.  We will soon demonstrate our ability to become one of the lowest cost operators producing pesticide-free, premium quality cannabis products, and achieving true vertical integration by:

  • leveraging our purpose built, large-scale, high technology cGMP designed greenhouse in Cathedral City (the “Sunniva California Campus”);
  • accelerating production within our licensed volatile and non-volatile extraction facility in Cathedral City, California (the “Extraction Facility”);
  • producing and stockpiling inventory for Sunniva-branded product launches commencing Q1 2019;
  • completing the pending acquisition of LTYR Logistics, LLC (“LTYR”) for state-wide distribution of Sunniva-branded products;
  • aggressively pursuing dispensary retail expansion throughout California; and
  • integrating our additions to the California management team to facilitate growth and revenues in 2019.

Dr. Holler continued, “In Canada, we concluded our formal engagement with Canaccord Genuity Corp. to conduct a thorough examination of the Canadian cannabis market to define Sunniva’s strategy for our Canadian operations. We can confirm the Company intends to spin-out its Canadian assets (the “Spin-Out”) into a separate Canadian entity (“Spinco”).  Our Canadian assets include Natural Health Services Ltd. (“NHS”), which owns our seven physician-based medical clinics throughout Canada and Sunniva Medical Inc. (“SMI”), which is our licensed producer applicant and owns the 126-acre parcel of land in Okanagan Falls, British Columbia, the site for a large-scale, purpose-built cGMP designed greenhouse (the “Sunniva Canada Campus”).”

Financial Highlights – Three and Nine Months Ended September 30, 2018

Consolidated Financial Highlights expressed in 000’s of CDN$, except per share amounts

  Three Months Ended September 30,
2018 2017 Change
 Revenue 3,739 4,562 (823 )
 Cost of Goods Sold 1,634 2,834 (1,200 )
 Gross Margin 2,105 1,728 377
 Selling, General and Administrative 6,420 5,089 1,331
 Share-based Payments 2,303 3,311 (1,008 )
 Amortization Expense 751 660 91
 Loss from Operations (7,369 ) (7,332 ) (37 )
 Net Loss (6,781 ) (6,247 ) (534 )
 Basic Loss Per Share $ (0.21 ) $ (0.25 ) $ 0.04
 Weighted Average Number of Shares 32,042,054 25,374,940 6,667,114
 Total Number of Shares Outstanding 32,054,215 26,623,016 5,431,199
  Nine Months Ended September 30,
2018 2017 Change
 Revenue 13,372 10,215 3,157
 Cost of Goods Sold 6,386 6,036 350
 Gross Margin 6,986 4,179 2,807
 Selling, General and Administrative 16,933 9,830 7,103
 Share-based Payments 6,408 3,311 3,097
 Amortization Expense 2,171 1,792 379
 Loss from Operations (18,526 ) (10,754 ) (7,772 )
 Net Loss (17,961 ) (17,953 ) (8 )
 Basic Loss Per Share $ (0.59 ) $ (0.72 ) $ 0.13
 Weighted Average Number of Shares 30,386,117 25,101,369 5,284,748
 Total Number of Shares Outstanding 32,054,215 26,623,016 5,431,199


Results of Operations – Three Months Ended September 30, 2018

For the three and nine months ended September 30, 2018, the Company generated $3.7 million and $13.4 million in revenue, respectively. NHS contributed $2.5 million and $8.4 million, Full-Scale Distributors, LLC (“FSD”) contributed $1.1 million and $4.9 million, and CP Logistics, LLC contributed $0.1 million over these same periods. Net loss for the three and nine months ended September 30, 2018 was $6.8 million and $18.0 million as compared to $6.3 million and $18.0 million during the three and nine months ended September 30, 2017.

The key components contributing to the change in net loss from the three and nine months ended September 30, 2018 compared to the prior comparative periods comprise the following:

  • Revenue decreased by $0.8 million during the three months ended September 30, 2018 and increased by $3.2 million during the nine months ended September 30, 2018 as compared to the respective comparative periods.  NHS revenue decreased by $0.7 million during the three months ended September 30, 2018 due to a decline in the number of prescriptions written over the comparative period; however, NHS revenue increased by $1.0 million during the nine months ended September 30, 2018 due to an increase in the number of clinics and Licensed Producers (“LPs”) under contract over the comparative period.  FSD revenue decreased slightly by $0.2 million during the three months ended September 30, 2018 but increased by $2.1 million during the nine months ended September 30, 2018 due to an increased customer base and strong first quarter 2018 results.  The increase over the comparative nine months ended September 30, 2017 is also due to the acquisitions of NHS and FSD midway through February 2017.
  • Gross margin increased by $0.4 million and $2.8 million during the three and nine months ended September 30, 2018 primarily due to the increase of LP revenue in NHS.  LP revenue provides the highest margin of all the Company’s revenue streams.  On a percentage basis, gross margin increased from 38% and 41% in the three and nine months ended September 30, 2017 to 56% and 52% in the three and nine months ended September 30, 2018 due to the increase in LP revenue.
  • Selling, general and administration expenses increased by $1.3 million and $7.1 million during the three and nine months ended September 30, 2018.  The increase is primarily due to an increase in operational spend with the Company’s continued expansion, higher costs associated with being a publicly-listed company and increased advisory costs related to the development of the cultivation businesses in California and Canada.   The most significant increase in costs relate to professional fees, personnel costs and rent.  The increase over the comparative period is also due to the acquisitions of NHS and FSD occurring midway through the first quarter of fiscal 2017.
  • Share-based payment expenses were $2.3 million and $6.4 million in the three and nine months ended September 30, 2018 compared to $3.3 million in the three and nine months ended September 30, 2017 with the introduction of the Company’s stock option plan mid-way through fiscal 2017.
  • The Company realized a non-cash gain of $1.0 million on settlement of a secured convertible promissory note issued in connection with the acquisition of FSD in the first quarter of fiscal 2018.
  • Fair value changes in derivative instruments due to the revaluation of secured convertible promissory notes and warrants went from a gain of $0.3 million and an expense of $8.7 million for the three and nine months ended September 30, 2017 to gains of $1.1 million and $0.8 million for the three and nine months ended September 30, 2018.  This was due to a decrease in the Company’s share price in the third quarter of fiscal 2018 and significant fair value changes in fiscal 2017 with the Company’s private share value increasing throughout fiscal 2017.
  • Amortization and depreciation expense increased by $0.1 million and $0.4 million during the three and nine months ended September 30, 2018 due to a higher cost base of the assets in fiscal 2018 and the intangible assets being acquired midway through the first quarter of fiscal 2017.
  • The Company’s cash position is $11.2 million as of the date hereof.

Recent Operating Developments Subsequent to September 30, 2018

  • On October 12, 2018, the Company completed the Offering for aggregate gross proceeds of $23.0 million.  A total of 4,370,000 units were sold at a price of $5.27 per unit. The Company intends to use the net proceeds from the Offering for construction and operations at the Sunniva Canada Campus and Sunniva California Campus, with the remaining amount funding working capital.
  • On October 16, 2018, the Company signed a letter of intent with a related party, the Oakland Vision Project (“Vision”), to acquire all the issued and outstanding equity interests of the companies that comprise Vision. Vision is jointly owned by Vinayak Shastry, the Company’s President of U.S. Operations.  Vision operates a licensed cultivation facility located in Oakland, California (the “Oakland Facility”) and currently has a contract to supply the Sunniva California Campus with clean clones to initiate production. Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between the Company and Vision, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange.
  • In November 2018, the Company transitioned from the OTCQX to the OTCQB as a consequence of the decrease in the Company’s share price on the OTCQX which resulted in the Company no longer meeting the qualification requirement that it relied on for the purposes of listing.  The Company will continue to trade under the symbol “SNNVF” and it will have no effect on the reporting obligations of the Company in the United States.
  • On November 26, 2018, the Company signed a binding letter of intent with LTYR, a cannabis distribution company in California that is expected to become Sunniva’s logistics and technology distribution platform to drive sales from Sunniva’s large-scale cannabis production and manufacturing facilities and the launch of Sunniva-branded products commencing Q1 2019.  LTYR will also utilize Sunniva’s Cathedral City distribution and delivery license.  The principal members of LTYR will also perform key management and sales roles in California.  LTYR will continue to generate revenues and expand its existing relationships with over 120 licensed dispensaries throughout California.  Concurrently, Sunniva is purchasing a 4,200 sq. ft warehouse in Long Beach, California that, once licensed and operational, will serve as an additional distribution hub for Sunniva and will expand the Company’s distribution reach from the southern border to San Francisco.  The City of Long Beach is a cannabis friendly region and the warehouse is situated in an industrial district that has been zoned for cannabis business operations.  Renovations and receipt of licensing requirements are expected to be completed in Q2 2019.  Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between the Company and LTYR, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange.

Copies of our interim financial statements for the three and nine months ended September 30, 2018 and related management’s discussion and analysis of financial results are available on SEDAR at www.sedar.com.

California Operations Update

  • Construction is nearing completion for Phase 1 of the Sunniva California Campus and is expected to be completed in Q1 2019. Total production capacity of Phase 1 is projected to be 50,000 kg (50 million grams) per year of premium indoor cannabis when fully ramped up.  A total of 100,000 plants from the Oakland Facility are being prepared for onboarding for the initial planting cycle in Q1 2019.  Automation will move the plants through their life cycle and when operating at full capacity, the Sunniva California Campus is expected to deliver a continuous daily harvest of approximately 210 kg (2.1 million grams) of dried flower. We continue to work toward the completion of our California state licensing requirements for the Sunniva California Campus. The cultivation licenses are currently being processed and the remaining license applications are being prepared for submission to the state of California. The Company does not expect operational delays from these licensing requirements.  The Sunniva California Campus will be a 489,000 sq. ft. state-of-the-art, purpose-built cGMP facility capable of producing 72,500 kg (72.5 million grams) per year of dried flower at peak capacity once construction of Phase 2 is completed.
  • The Extraction Facility, licensed for both volatile and non-volatile extraction processes, commenced operations in July 2018. The extraction team has been manufacturing and perfecting its extracted product lines and developing product formulations.  Sunniva is currently stockpiling inventory in preparation for the launch of Sunniva-branded product lines in Q1 2019.  The Extraction Facility has the ability to produce vape oil-distillate, ultra-pure concentrates, fresh frozen, shatter, capsules, tinctures, and edibles.  The Extraction Facility adheres to cGMP standards and has the capacity to process over 10,000 lbs of cannabis biomass a month.  Sunniva continues to source compliant third-party biomass and trim through existing relationships which will drive revenues in early 2019.  Reliance on purchases of third-party biomass will be reduced as production from the Sunniva California Campus becomes available.
  • We have been evaluating many retail expansion opportunities to complement our vertical integration strategy.  In addition to the flagship dispensary being built at the Sunniva California Campus, our goal is to pursue other retail acquisitions to expand our footprint in this part of the integration chain.
  • Sunniva has strengthened its California management team in preparation for full operations in 2019.  We have hired Kevin Wilkerson as COO of California operations, Tom Brozowski as Vice President Operations, Andrew Pruett as Vice President of Technology, Jay Myers as Vice President of Sales, Brad Neeld as Vice President of Distribution and Victor Ide, Manager of Human Resources.

Canada Operations Update

  • Our business strategy in Canada will shift from becoming a wholesaler of cannabis to a focus on the higher margin direct to patient medicinal cannabis market. Currently in Canada, there are approximately 400,000 registered cannabis patients, with that number forecasted to grow to over two million registered patients in the next three years.  NHS has 105,000 registered patients to date and with 100% ownership of seven physician-based clinics across Canada, we feel we have a significant competitive advantage in capturing additional market share in this area.
  • We have defined a clear path to accelerate our licensing and production timelines through SMI at the Sunniva Canada Campus by starting construction of a smaller modular phased approach that will require less than $1.5 million in cash capital expenditures.  Production from this modular phase will be key to achieving our goal of 20,000 registered patients in 2019 and over 50,000 in 2020.  We intend to increase future production capacity through phased development of the Sunniva Canada Campus.
  • The Company intends to spin out its Canadian assets into Spinco and apply to list the shares of Spinco on the TSX Venture Exchange (“TSX-V”) first half of 2019.

Spin-Out Steps and Anticipated Timelines

  • Borden Ladner Gervais LLP has been engaged to handle the legal aspects of the Spin-Out including outlining the steps, timeline, preparation of the information circular and making the necessary regulatory and court applications.
  • PricewaterhouseCoopers LLP has been engaged as tax advisors to conduct the tax assessment and valuation of the Spin-Out to determine the allocation of value of the Canadian and US entities.
  • MNP LLP has been retained as the auditors to conduct the audit of the carve-out financial statements of Spinco.
  • Q1 2019 – set record date and mail out of information circular which will include information on the management, board of directors and financial statements of Spinco.
  • Q1/Q2 2019 – meeting of the shareholders to vote on the transaction.
  • Q2 2019 – shares of Spinco expected to begin trading on the TSX-V.

Canada Business Plan

  • Sunniva has the infrastructure to capture significant market share within the medicinal cannabis market:
    • Market estimated to reach over two million patients in the next three years
    • Insurance companies and unions providing medical cannabis coverage under group benefit plans
    • Physicians are the gatekeepers to achieving market share
    • High margin, LP direct to patient distribution business model
    • BMO Capital Markets estimate medical sales price of $8.50 per gram for the next three years with the current average patient spend of $2,000 per year
  • Patient capture through 100% ownership of NHS cannabis clinics and technology platform:
    • Seven specialized brick and mortar cannabis clinics in four provinces (AB, SK, MB, ON)
    • Over 105,000 registered patients
    • 18 health care professionals (GPs, specialists) and two nurse practitioners
    • Creating an online virtual e-commerce clinic platform for education, telemedicine and sales
    • Planned collaboration with universities for research and development
  • SMI received Confirmation of Readiness for a cultivation license under the Access to Cannabis for Medical Purposes Regulation from Health Canada on May 26, 2018 – SMI’s application is approved and subject to initial phased build and readiness
  • Phase 1 Modular fast- tracked facility (planned flower capacity ~5,000 kg/year)
    • New cultivation modules expected to be delivered to site January 2019
    • Cannabis genetics already sourced for production
    • Submit for cultivation license approval – January 2019
    • Estimate registering 20,000 medical patients in 2019, over 50,000 in 2020
    • Estimated costs < $2.50/gram pharma-grade, pesticide-free producer
    • Initial capital of $1.5 million with additional production modules to be vendor financed
    • Estimate receipt of sales license and first harvest by Q3 2019
  • Phase 2 – 458,000 sq. ft (50,000 kg per year flower capacity)
    • State-of-the-art, purpose built, cGMP designed greenhouse
    • Low cost < $1.00/gram pharma-grade, pesticide-free producer
    • Subject to financing and license approvals
  • Phase 3 – 301,000 sq. ft (50,000 kg per year flower capacity)
    • State-of-the-art, purpose built, cGMP designed greenhouse
    • Low cost < $1.00/gram pharma-grade, pesticide-free producer
    • Subject to financing and license approvals

Please see the updated Corporate Presentation and Fact Sheet at www.Sunniva.com/Investors/

To be added to the Sunniva email distribution list, please email Sunniva@kcsa.com with Sunniva in the subject line.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva-branded products in various product categories including premium concentrates, vape cartridges, flower, pre-rolls, and beverages as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding the Company’s operations and growth opportunities, the Company’s expansion of its footprint in the U.S., the Company’s vision to become one of the lowest cost, highest quality vertically integrated cannabis producers in the markets we serve by building large scale purpose-built current cGMP designed greenhouses and expansion of retail locations, offering better quality assurance with cannabis products free from pesticides, providing better customer access to cannabis education and sourcing better therapeutic delivery devices, the profitability of the Company’s facilities and operating subsidiaries, the expected dramatic increase in demand for cannabis in Canada following legalization of cannabis, the costs and expected production at the Sunniva California Campus and the Sunniva Canada Campus, the timing and conditions relating to the Spin-Out, the Sunniva California Campus being operational in Q1 2019 with the first harvest expected in Q2 2019, the ability of the Company to launch Sunniva-branded product lines in California and propagate the Sunniva California Campus with clean clones, the conditions of closing for the acquisition of Vision, the conditions of closing for the acquisition of LTYR, the expectation that LTYR will continue to generate revenues and expand its existing relationships with over 120 licensed dispensaries throughout California, the timing of renovations and receipt of licensing requirements for the warehouse in Long Beach, California, the impact of the transaction with LTYR on the Company and LTYR’s expected role as the Company’s logistics and technology distribution platform, the Company’s expectation that there will be no operational delays from the California licensing requirements for the Sunniva California Campus, the Company’s anticipated production and brand roll-out at the Extraction Facility, the reduction of reliance on purchases of third-party biomass as production from the Sunniva California Campus becomes available, the Company’s goal to pursue other retail acquisitions in California, the Company’s shift in focus from becoming a wholesaler of cannabis to the direct to patient medicinal cannabis market in Canada, the expected growth of the number of registered cannabis patients in Canada, the estimated medical sales price for the next three years and average patient spend, the Company’s expected use of proceeds from financings, and statements regarding the plans, timing and conditions of the Spin-Out, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Company Contact:

Dr. Anthony Holler
Chairman and Chief Executive Officer
Phone: (866) 786-6482

Investor Contact:                                                          Media Contact:
Phil Carlson / Erika Kay                                                  Katelyn Tumino
KCSA Strategic Communications                                   KCSA Strategic Communications
Phone: (212) 896-1233                                                   Phone: (212) 896-1252
Email: pcarlson@kcsa.com / ekay@kcsa.com               Email: ktumino@kcsa.com

Wednesday, November 28th, 2018 Uncategorized Comments Off on $SNNVF Q3 2018 Financial Results, Strategic Update on Canadian Operations

$PNNRF Cannabis Strategic Ventures, Water-Soluble Cannabis Technology JD

VANCOUVER, British Columbia, Nov. 28, 2018 — Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products.  Under the agreement, Biolog will develop the new technologies with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.

Cannabinoids (CBD, etc.) are hydrophobic substances which are not typically soluble in water. To date, cannabis formulators have utilized various techniques to make CBD oils water compatible, but encounter many drawbacks in the existing processes. The joint development effort between Biolog Inc. and Cannabis Strategic Ventures will seek to push past these current limitations to develop a new set of functional cannabinoid ingredients that can be easily added to foods, beverages, cosmetics and other consumer products that significantly improve bioavailability and overall benefits to the human body.

Simon Yu, CEO, Cannabis Strategic Ventures comments, “We believe water-soluble cannabis technologies open new avenues for the development of cannabinoid-based products.”  He added,  “Over the past year we have reviewed several supposed water-soluble cannabinoids technologies but have passed on adoption due to technological limitations. The new product class that is in development with Biolog holds great potential and we are enthusiastically backing this developmental effort.”

“Working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space. Branded products are the niche we believe will lead the industry just as patented medical products lead pharma for many decades. Biolog’s licensing agreements with Lexaria makes them a leader of the medical cannabis pack. This client in our portfolio looks to be our next go-public prodigy,” stated Meris Kott, CEO, Redfund Capital Corp.

About Redfund Capital

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

About Cannabis Strategic Ventures

Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands.

About Biolog, Inc.

Privately held Biolog, Inc., located in the San Francisco Bay area, has been organized to capitalize on the fast growing market for cannabidiol (CBD) edibles and beverages. Biolog products solve many of the industry’s most pressing issues concerning cannabis edibles and beverages by offering precise dosing, micro-dosing, fast onset times, high bioavailability, taste masking and ease of use.

For further information on Redfund Capital please visit www.redfundcapital.com
For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 or info@redfundcapital.com

For further information on Cannabis Strategic Ventures, Inc. please contact Arlene Guzman Phone:+1-310-359-6860 Email: ir@cannabisstrategic.com
Website: http://www.cannabisstrategic.com

Further information about the Company is available on www.SEDAR.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Wednesday, November 28th, 2018 Uncategorized Comments Off on $PNNRF Cannabis Strategic Ventures, Water-Soluble Cannabis Technology JD

$RIV.V 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants

A team of researchers interested in finding out whether cannabis could treat PTSD (post-traumatic stress disorder) among veterans finally registered its 76th study participant on Veterans Day.

The Scottsdale Research Institute located in Phoenix, AZ got permission from the FDA to conduct the research in 2010. The researchers then started recruiting study participants in 2016 but hit several speed bumps in their efforts to get the required minimum number of participants (76 veterans).

First, the researchers were denied access to the veterans’ hospital just 20-miles away from the facility where the research is being conducted. The Veterans Affairs department refused to grant access because federal laws regarded cannabis as a substance that didn’t have any medicinal value.

Public hospitals and universities in Arizona also refused to cooperate with the researchers as they recruited study participants citing federal laws as restricting them from being part of a study on an illegal substance.

These challenges nearly made the researchers widen the scope of the research so that non-veterans could also be allowed to enroll.

However, such a move would have defeated the purpose of the study since the researchers were specifically interested in investigating whether cannabis could treat PTSD in military veterans. The search for participants therefore dragged on as thousands were screened and rejected for not meeting the strict requirements of the study.

Gradually, the number of eligible participants started growing until the climax was reached almost two years after the recruitment exercise for participants started.

The researchers now have the 76 participants that they need to proceed with their randomized, controlled study of how marijuana can help veterans with chronic forms of PTSD.

Each day, the study participants will be given 1.8 grams of marijuana. This cannabis will vary in potency and the participants will keep a journal of how they feel or anything else noteworthy during the study period. The participants will also be free to decide how much of that daily ration to smoke.

The study subjects will visit the research institute 17 times during the 12-week duration of the study. The participants will then be followed up for six months after the initial 12-weeks of treatment with cannabis.

The researchers hope to publish their findings in 2019 after getting a definitive answer of whether cannabis can treat PTSD in veterans, and whether it has any adverse effects on those former servicemen and women.

This research comes at a time when efforts are being made to pass House Bills aimed at regulating and granting access to medical cannabis by veterans. The scientific community and cannabis industry players, such as Cannabis Strategic Ventures, Inc. (OTC: NUGS) and Canopy Rivers Inc. (TSX.V: RIV) await the results of this Phoenix study.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Wednesday, November 28th, 2018 Uncategorized Comments Off on $RIV.V 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants

$TGODF Expansion of CBD – Hemp Continues to Explode as Demand, Sales Revenues Climb

Palm Beach, FL – (October 2, 2018) – While there may have been a recent pull back on Cannabis stocks, one thing that remains strong is the grow operations show no signs of slowing and instead continue to expand.  The cannabis industry’s growth is forcing industry cannabis focused companies to evaluate the current state of their operations, both in terms of scale and efficiency. Despite market conditions, more importantly as demand rises and retail sales improve, companies are still choosing to expand operations with investment and innovation. Driving the demand could also be attributed to the change in federal policy in the U.S. and recent legalization of recreational marijuana in Canada.  According to Bill Sumner, a Hemp Business Journal contributor, as the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill.  Active cannabis companies in the markets this week include Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), Liberty Health Sciences Inc. (CSE:LHS) (OTC:LHSIF), GW Pharmaceuticals plc (NASDAQ:GWPH), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).

Global Hemp Group Inc. (CSE:GHG.CN) (OTCPK:GBHPF) BREAKING NEWS:  Global Hemp Group and its joint venture partner Marijuana Company of America, Inc. (OTC:MCOA) (the “Partners”) are pleased to provide an update on the harvest at their high yielding CBD hemp project in Scio, Oregon.

The 2018 Scio cultivation consisted of 33 acres of high yielding CBD hemp (utilizing six different cultivars with an expected CBD content ranging from 6% to 12%) was grown in an orchard style cultivation on the two lower fields at the property. With the help of near perfect weather in the region extending the harvest period by several weeks, the hemp had the opportunity to grow to full maturity and allowed the team to completely harvest all plants grown, before the fall rains began in the valley. For pictures from this season’s cultivation, please visit the Scio project page on GHG’s website – https://globalhempgroup.com/scio-oregon.

As with most things on the hemp farm this year, innovation was the key to success. There were many challenges throughout the year; from getting a late start due to delays in closing of the farm acquisition, to preparing the fields, drying, harvesting and storage, but the team in Scio was able to find solutions when required. Our team consists of a number of crew members that are extremely innovative, who are trained in a variety of skill sets. They are well versed in everything from metal fabrication, fine carpentry, and large equipment operation, so the team is able to set up, build, and/or operate pretty much everything themselves at the project. With the addition of a number of knowledgeable advisers to assist, the team was able to solve all challenges that arose during the course of the season.

The Harvest – This year’s harvest consisted of approximately 37,000 high yielding CBD hemp plants producing 24 tons of biomass. Harvesting this year was done by hand, making it extremely labour intensive and time consuming. The team has created a number of solutions that will automate both the harvesting and planting of the hemp for next year’s crop. Ultimately, the goal is to completely automate these processes, making it more efficient and less costly to complete. The team has now begun working on prototypes to automate the harvesting processes and expect to have machinery ready for use next season.

Drying – A number of different drying techniques were employed with this year’s harvest. In the end, “old school” hanging techniques proved to be the most effective and efficient. Drying took place in the farm’s larger 20 foot high, 4,000 sq. ft. greenhouses which allowed for an increased quantity of plants being dried at any one time. Drying took approximately 36 to 48 hours to dry the hemp to be levels required for storage and ultimately extraction. With each successive batch of drying, techniques were improved to increase the volume of biomass being dried in the greenhouse, while decreasing the time that it took to hang and dry it.

Results – The drying process for all of the hemp harvested is now complete and is stored awaiting further processing. The farm produced 48,000 pounds of dried biomass, which is stockpiled in quarter ton super sacks, stacked three bags high and requiring approximately 4,000 sq. ft. of storage space. Despite the late start in planting this season, the hemp plants still achieved sufficient size to produce the anticipated quantity of biomass. It is expected that in 2019, planting will begin June 1st giving the hemp an addition 30-45 days of growing time. This will produce much larger plants, resulting in significantly larger quantities of biomass.   Read this and more news for Global Hemp Group at http://www.financialnewsmedia.com/news-ghg


Other recent developments in the cannabis industry include:

Liberty Health Sciences Inc. (CSE:LHS.CN) (OTCQX:LHSIF) recently announced it plans to open two new dispensaries in Miami and Dania Beach by the end of November and three more in Hollywood, Bonita Springs and Orange Park by the end of this December. Each of the dispensaries will feature free 24-hour delivery service throughout their service area. The new dispensaries are located at 6827 Bird Road, Miami, FL.; 1103 South Federal Highway, Dania Beach, FL.; 2119A Hollywood Blvd., Hollywood, FL.; 24611 Production Circle, Bonita Springs, FL.; 1907-3 Wells Road, Orange Park, FL. The dispensaries are open Monday through Friday, 10 a.m. to 7p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. Currently, Liberty operates seven dispensaries and six delivery hubs throughout Florida. By the end of the calendar year, Liberty plans to have 12 dispensaries open throughout the state, subject to the receipt of Florida Department of Health approvals.

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) announced last week the completion of the previously announced plan of arrangement (the “Arrangement”) pursuant to which Aurora has acquired all of the issued and outstanding common shares of ICC for $1.95 per share (payable in common shares of Aurora (the “Aurora Shares”)), reflecting an aggregate purchase price of approximately $290 million . ICC is now a wholly-owned subsidiary of Aurora. Completion of the Arrangement follows receipt of approval of the Arrangement from the Instituto de Regulación y Control del Cannabis, the Uruguayan regulatory authority overseeing the regulation and control of cannabis in Uruguay. ICC’s common shares will be delisted from the TSX Venture Exchange (the “TSX-V”), subject to TSX-V approval, and applications will be made for ICC to cease being a reporting issuer. The acquisition of ICC establishes Aurora as the industry leader in Latin American, a region which encompasses more than 650 million people from across Mexico , the Caribbean , Central America , and South America . ICC, based in Uruguay , the first country in the world to legalize cannabis for adult consumer use, has developed a strong portfolio of high-quality, low-cost production assets, product offerings, and commercial agreements.

GW Pharmaceuticals plc (NASDAQ:GWPH) recently announced positive top-line results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Dravet syndrome, a rare and severe form of childhood-onset epilepsy. In this trial, EPIDIOLEX, when added to the patient’s current treatment, achieved the primary endpoint of reduction in convulsive seizures for both dose levels (10 mg/kg per day and 20 mg/kg per day) with high statistical significance compared to placebo. Both EPIDIOLEX doses also demonstrated statistically significant improvements on all key secondary endpoints. “The positive outcome in this second trial of EPIDIOLEX in patients with Dravet syndrome further reinforces the effectiveness of this newly available medicine in this particularly difficult to treat, childhood-onset epilepsy,” stated Ian Miller, M.D., Director, Epilepsy and Neurophysiology Program at Nicklaus Children’s Hospital in Miami, FL and principal investigator of the trial. “The totality of data from the controlled clinical trials completed for EPIDIOLEX have shown clinically meaningful seizure reductions and a consistent safety and tolerability profile. I am excited that this recently approved and important new treatment option is now available for my patients.”

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) recently announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada. Velvet is a new company with distinct ownership created by the largest wine distributor in Canada, Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated twenty four hundred dollars for news coverage of the current press releases issued by Global Hemp Group Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Tuesday, November 27th, 2018 Uncategorized Comments Off on $TGODF Expansion of CBD – Hemp Continues to Explode as Demand, Sales Revenues Climb

$SNNVF Acquisition of California Distribution Company Primes Branded Cannabis Products

  • LTYR Logistics, LLC to become Sunniva’s logistics and technology distribution platform to drive sales from Sunniva’s large-scale cannabis production facilities, following the launch of Sunniva branded products commencing Q1 2019
  • Sunniva acquires highly skilled management and sales team with a retail network of more than 120 licensed retail dispensaries throughout California
  • Compliant distribution is a vital segment of the highly regulated California cannabis industry with track and trace implementation coming in January 2019. For all movement of cannabis products in California, distributors are subject to additional responsibility for product testing and safety as well as state tax collection

VANCOUVER, British Columbia, Nov. 27, 2018  — Sunniva Inc. (“Sunniva” or the “Company”) (CSE: SNN) (OTCQB: SNNVF), today announced the acquisition of 100% of LTYR Logistics, LLC (“LTYR”) (the “Acquisition”), a California-based cannabis distribution company headquartered in San Diego. LTYR’s strong leadership and proven ability to effectively execute growth strategies utilizing its distribution capabilities within the cannabis space are the primary drivers of this acquisition. LYTR will play an instrumental role in driving Sunniva’s leadership position in California as a truly vertically integrated cannabis company across the entire value chain, from seed to sale.

Kevin V. Wilkerson (CEO) leads the LTYR team and has joined Sunniva as the Chief Operating Officer of Sun CA Holdings, Sunniva’s 100% owned California operating subsidiary. Mr. Wilkerson is a Harvard Masters degree graduate and has been a successful entrepreneur in numerous businesses. Kevin has been active in the cannabis space since 2014, providing operations, distribution logistics and technology expertise to the industry. He retired as a Colonel in the US Army after a distinguished 24 year career where he commanded over 4,000 troops and received the Bronze Star. In connection with the acquisition, Mr. Wilkerson will be responsible for all of Sunniva’s California operations.

The other co-founders of LTYR have also joined Sunniva in various management roles. Jay Myers will become Vice President of Sales in California and Brad Neeld will become Vice President of Distribution. Mr. Myers has operated in sales within the cannabis space in both Colorado and California since 2012 following a successful executive management, sales/marketing, and leadership career for companies such as West Coast Consulting and Bank of America. Prior to that, he served 12 years as a Navy SEAL. Mr. Neeld was one of the first large-scale commercial cultivators in Colorado before entering distribution in California. His retail relationships and cultivation knowledge reach far beyond distribution strategies and include scientific aspects of the cannabis core DNA and molecular strain structure.

“Over the last six months, we have evaluated several distribution opportunities to complement our vertical integration strategy with the goal of being able to sell all of the products we produce in our California facilities. Our operations and marketing teams have been working closely with the LTYR team analyzing consumer market data, demand metrics and pricing economics to better define all upcoming Sunniva product lines in preparation of our brand launches commencing in the first quarter of 2019. Kevin and his team are proven distribution, operations and execution specialists and we have the utmost confidence in their distribution capabilities as Sunniva ramps up for large-scale production in 2019 from both of our high-tech greenhouse and extraction facilities,” said Dr. Anthony Holler, CEO of Sunniva. “Over the past quarter, we have been actively manufacturing and stockpiling inventory for our brand launches and we are excited about achieving significant revenue from all our vertical growth opportunities in 2019.”

Kevin Wilkerson, CEO of LTYR Logistics added, “One of the biggest challenges that distribution companies in California are experiencing is getting access to compliant, pesticide-free cannabis products on a large-scale. Compliant cultivation at scale is the quintessential pillar in California for the future success of any brand, distribution company or retail chain. We are very excited to join a preeminent partner like Sunniva that will ensure safe, reproducible, premium-quality cannabis products on a very large scale. After touring both Sunniva’s 325,000 square foot purpose-built cannabis greenhouse and the extraction facility in Cathedral City, we were very impressed with the level of meticulous design and implementation of top tier commercial agriculture technologies and automation. While we had a variety of opportunities available to us, partnering with Sunniva was the most logical choice for our shareholders to take our business to the next level.”

LTYR – Further Information

  • Revenue generating and operating in partnership under a third-party distribution license in Northern California
  • LTYR to utilize Sunniva’s existing Cathedral City distribution and delivery license
  • Sunniva purchasing a 4,200 sq. ft. proposed distribution facility in Long Beach, CA
  • Fully automated sorting, weighing, packaging machines for large-scale distribution
  • Additional distribution platform for real-time delivery solutions
  • LTYR to be compliant with “track and trace” regulations coming January 2019 to California

LTYR – Transaction Details

  • Binding term sheet signed for the acquisition of 100% of the equity interests of LTYR
  • Consideration: 1,861,971 of Sunniva common shares at CAD $4.26 per share with 620,657 of such shares to be subject to achieving operational milestones
  • Expected Closing Date by the end of Q4 2018. Closing is subject to conditions, including negotiation and execution of definitive agreement, receipt of any required approvals, and satisfactory completion of due diligence.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including flower, pre-rolls, premium concentrates, vape cartridges, edibles and beverages. We will have inhouse compliant distribution and continue to aggressively pursue retail expansion in the near term in California. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”), including, but not limited to, statements relating to the proposed benefits of the Acquisition and the plans for Sunniva, and statements with respect to the conditions of completing the Acquisition, including negotiating and executing the definitive agreement and regulatory approvals. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Phone: (866) 786-6482

Investor Contact:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contact:
Katelyn Tumino
KCSA Strategic Communications
Phone: (212) 896-1252
Email: ktumino@kcsa.com

Tuesday, November 27th, 2018 Uncategorized Comments Off on $SNNVF Acquisition of California Distribution Company Primes Branded Cannabis Products

$NUGL Scales Broad Launch Into the Cannabis Industry

LOS ANGELES, Nov. 27, 2018 — via NEWMEDIAWIRE — NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry’s new standard of technology, is pleased to announce a full-scale marketing launch into the cannabis industry from all NUGL platforms and publications.

“We have listened to our community and made the proper changes to the software.  We have tested all marketing campaigns and we are now ready to aggressively scale these efforts.  It is time to get the word out there and allow us to connect businesses and consumers in a highly efficient manner,” stated Ryan Bartlette, Chief Marketing Officer at NUGL.

NUGL has created a broad network of social media influencers, combined traffic and users from the acquisition of two publications and is in the process of launching NUGL Magazine, a new culture-based publication in the cannabis space.  The coordinated launch of NUGL Magazine and collective assets is expected to increase online, monetizable visitors by the millions and generate a viral push.

NUGL has also ramped attention through various media companies such as Money TV, a leading investment network where NUGL was featured last week.  NUGL has been asked to participate in a follow-up show updating the network on location from a dispensary in Los Angeles called “Da Spot” at Circle of Life Dispensary operated by Chonsie Bullock.

“We are excited about NUGL and integrating the software into our business.  NUGL offers unique tools to network and grow sales. Nothing like this has ever been done in the cannabis space,” stated Bullock.

NUGL intends to penetrate the market in a significant way, bypassing the conventional ways of the cannabis industry markets.   With three growing, influential publications and software with proprietary and unparalleled networking features, NUGL is positioning itself for rapid expansion in 2019.

About NUGL

NUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

For more information and updates, visit one of the links below.

Website: http://www.nugl.com/
Facebook:  https://www.facebook.com/nuglapp/
Instagram: https://www.instagram.com/nuglapp/
Twitter: https://twitter.com/nuglapp/

LinkedIn: https://www.linkedin.com/company/nuglapp/

Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: “plans”, “anticipates,” “expects,” “believes” or similar words of like kind. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in the company’s business plan and filings with the OTC Markets Group.

Contact Information:

Website: www.nugl.com
Email: info@nugl.com
Phone: (714) 383-9982

Investor Relations & Financial Media

info@integrityir.com

Toll Free: (888) 216-3595

www.IntegrityIR.com

Tuesday, November 27th, 2018 Uncategorized Comments Off on $NUGL Scales Broad Launch Into the Cannabis Industry

$DPW Authorizes Pursuit of Spinoff of Super Crypto Mining

NEWPORT BEACH, Calif., Nov. 27, 2018 — DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (“DPW,” or the “Company”), announced today that its Board of Directors, at a meeting on Friday, November 23, 2018, has authorized the officers of DPW to pursue a spinoff of DPW’s wholly-owned subsidiary Super Crypto Mining, Inc. (“Super Crypto”). The Company’s action demonstrates its confidence in the long-term viability of crypto-mining and the cryptocurrency marketplace and endeavors to provide Super Crypto’s management team the tools and independence necessary to achieve and surpass its goals in 2019 and beyond. The Company intends to declare a distribution of shares of common stock of Super Crypto to the stockholders of DPW, with the date of the distribution to be determined once a registration statement on Form 10 has been declared effective by the SEC and the information statement has been mailed to DPW’s stockholders. DPW believes that the spinoff will benefit both DPW and Super Crypto as well as their respective stockholders for many reasons, with the principal ones consisting of the following:

  •         The separation of the two businesses should not only enable their respective management teams to concentrate on the operations of the company for which they are responsible but also facilitate analysts’, market makers’ and others’ ability to ascertain the value of each entity and thus provide more clarity to the market through, among other reasons, being able to review two separate financial statements which could in turn lead to higher valuations for each entity;

           •         Investors, including portfolio managers and other institutional investors, who are interested in the cryptocurrency sector could initiate, maintain, or increase their position in Super Crypto, whereas investors who are not interested could take the alternate approach; as a result, the spinoff could enhance both companies’ ability to raise financing to expand their operations, among other objectives;

           •         Since a new board of directors would be established for Super Crypto, the members thereof should bring more expertise in the cryptocurrency sector to bear on their decision-making, and enable the members of the DPW Board of Directors to focus on a business with which they are more familiar; this in turn should lead to additional benefits such as a better allocation of capital and human resources; and

          •         Once spun off, Super Crypto should be able to use its shares as currency to pursue a variety of objectives, an option not presently available to it as DPW owns all its shares of its capital stock.

Any plan that the Company devises will be subject to approval by DPW’s senior secured creditor and certain regulatory bodies.

CEO and Chairman, Milton “Todd” Ault, III said, “As stated during our investor conference call on December 20, 2017, the acquisition of assets that would appreciate under our ownership and the creation of increased shareholder value through our portfolio companies and projects was our top priority. By spinning off our cryptocurrency assets, we are separating disparate businesses and providing the opportunity to hold stock in a pureplay crypto company. We are confident crypto-mining and the cryptocurrency marketplace will flourish in the long term and think there is significant value in Super Crypto and its various initiatives which require the ability to finance their growth independently. Regardless of the current downturn in the cryptocurrency space, we believe the assets of Super Crypto will be able to serve as the foundation of an independent company with the ability to raise its own capital. Further, this transaction positions Super Crypto Mining for a bitcoin recovery. It is our intent to declare a special dividend of no less than 80% of the common stock of Super Crypto to DPW stockholders.”

For more information, DPW recommends that stockholders, investors and any other interested parties read the Company’s public filings and press releases available under the Investor Relations section at www.DPWHoldings.com or available at www.sec.gov.

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com.

Forward-Looking Statements

This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.com and on the Company’s website at www.DPWHoldings.com.

 

Contacts: 
Mary Magnani and Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com###
Tuesday, November 27th, 2018 Uncategorized Comments Off on $DPW Authorizes Pursuit of Spinoff of Super Crypto Mining

$VVCIF 420 with CNW – Marijuana No Effect on Kidney Transplant Outcomes, Research

In the U.S., people who admit using or test positive for cannabis are routinely denied kidney transplants or turned away when they offer to donate their kidneys. This practice has gone unchallenged until a recent study proved that marijuana doesn’t affect the outcomes of kidney transplant surgery.

The research to find out how marijuana affects recipients of kidneys during and after the transplant surgery was partly inspired by the story of a man in Maine who was denied a kidney and even removed from the waitlist because he was a user of medical cannabis.

A group of researchers reviewed the transplant records at one kidney transplant facility from 2000 to 2016. The data on the donors and kidney recipients was grouped based on whether those people consumed cannabis or not.

31 of the donors reviewed were found to have used cannabis while 27 of the kidney recipients were also consumers of marijuana.

The comparison revealed that no difference existed between the recipients who got kidneys from consumers of cannabis and those whose donors didn’t consume cannabis.

The researchers concluded that facilities should start accepting donors who consume cannabis since the substance doesn’t have any discernible effect on the performance of the kidneys after the transplant surgery.

Such a shift would increase the pool of possible donors in order to reduce the long waitlists for matches between donors and potential recipients. Finding a match is already hard enough as it is, so there is no justification to prevent potential donors from participating just because those donors have a history of consuming cannabis.

The researchers hope that their findings trigger a discussion in the scientific community and the medical centers involved in conducting kidney transplants.

The walls and stereotypes surrounding marijuana seem to be collapsing one by one. It is refreshing to realize that debunking the myths and misconceptions on cannabis is being spearheaded by the scientific community. Their findings cannot be accused of fueling propaganda either for or against marijuana. They are simply putting the facts straight.

Hopefully, those scientific studies will trigger a mindset change in the collective consciousness of communities that have for decades been brainwashed into thinking that the cannabis plant was evil and was connected to many of the social ills plaguing different communities.

Cannabis companies like TransCanna and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) welcome the findings of the researchers studying the relationship between cannabis consumption and kidney transplant outcomes. Such findings validate some of the things that cannabis companies have been saying all along.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Tuesday, November 27th, 2018 Uncategorized Comments Off on $VVCIF 420 with CNW – Marijuana No Effect on Kidney Transplant Outcomes, Research

$TGODF CBD Products on the Rise

POINT ROBERTS, Wash. and DELTA, British Columbia, Nov. 26, 2018 — Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a snapshot looking at the growing global opportunity for CBD consumable products as regulations move towards global acceptance of CBD products.

Cannabis is fast becoming a growing sector, both in the medicinal and recreational sectors. As much as certain states and countries have begun to regulate this potential giant industry, CBD and specifically hemp strains of cannabis have begun to overshadow the general cannabis sector.

Seeing the opportunity at the start of 2018, EnviroTechnologies International, Inc., a publicly traded company (OTC: ETII) that develops and markets green, natural and organic products for diverse industries first announced the acquisition of CBD Health Co. (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, as a wholly owned subsidiary.

One of the products that uniquely position them as a public company is the CBD Hemp Protein, which caters to the health and sports markets. According to an article discussing its benefits “hemp—one of the most versatile plants on earth—offers a high-quality, eco-friendly source that can support muscle gain, fat loss, and peak performance.”

EnviroTechnologies International updated shareholders on this acquisition in today’s news. “We acquired CBD Health Co. because our company was founded to use green and natural products to make our environment safer and promote products that improve our quality of life,” said Gaylord Karren, ETI’s CEO. “And CBD Oil products have the potential to not only improve quality of their users’ lives but also create enormous revenues for our company and its shareholders.”

Continued: “For some time, experts have been making predictions about the global CBD market and the expanding acceptance of CBD as a natural health product. And some have predicted, specifically that the entire cannabis market could reach $20 billion by 2020 if the market expands at its current rate,” said Randall Waters, ETI’s Vice President of Sales and Marketing. “However, recent studies by the Brightfield Group, a company that specializes in providing data and information about the cannabis and CBD markets, avers that the hemp-based CBD market alone could reach $22 billion by 2022.”

Continued: “We see the markets for true hemp-based CBD products such as those produced by CBD Health, continuing to grow and the purchasing demographic multiplying over the next 3-4 years. We are satisfied that CBD Health is on the forefront of this incredible market and that we can tap into this new, accepted hemp-based CBD natural products,” said Waters.

Puration, Inc. (OTC: PURA), another company in the CBD space, recently released more details regarding its corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business.

Puration, Inc. is a leading Texas-based CBD-infused beverage provider, with the flagship product being EVERx, which Puration debuted early last year at Arnold Schwarzenegger’s ‘Arnold Sports Festival’.  EVERx has since become the leading CBD infused beverage in the sports nutrition marketplace. The Company recently spun-off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

CV Sciences Inc. (OTC:CVSI), operates as a life science company through two segments, Specialty Pharmaceuticals and Consumer Products. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods and vape.

CEO Joseph Dowling discussed the company’s Q3 Earnings Report earlier this month saying that, “The momentum from the first half of 2018 has continued and we anticipate a strong finish for the remainder of the year. Through our dedication and commitment to providing the most trusted brand of hemp CBD products we have achieved strong momentum in sales and brand recognition of our plus CBD product line. Our strategic priorities for 2018 include strengthening our distribution channels, growing our brand relevance and recognition, developing new products, penetrating new vertical sales channels and gaining market share in the fastest growing product category in the nutritional supplement industry.”

Even larger scale companies such as the Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) earlier this year expanded their CBD output by signing a definitive agreement to acquire 100% of the issued and outstanding shares of privately-held HemPoland.

HemPoland is a leading European manufacturer and marketer of premium organic CBD oils led by founder and CEO, Maciej Kowalski, one of Europe’s most widely recognized CBD experts. This strategic acquisition provides access to HemPoland’s vast distribution network, premium Cannabigold brand, state-of-the-art hemp oil extraction technologies and provides a strategic pathway into the European market for TGOD’s medical & recreational products and licensing deals.

As the CBD trend continues to rise, companies may realize the benefit of focusing strictly on the CBD/Hemp sector. Often noted as a sleeping giant in discussions, consumer awareness and education, plus potential legislative acceptance moves, including the 2018 Farm Bill, will make this a big story for investors moving forward.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com – News that Inspires Big Investing Ideas
https://www.investorideas.com/About/

Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/

This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com – third party , Learn more about costs and our  services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411

Monday, November 26th, 2018 Uncategorized Comments Off on $TGODF CBD Products on the Rise

$SNNVF Posting Q3 2018 Results on November 28

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) recently announced that it will be releasing financial results for the third quarter of 2018 after market close on Wednesday, November 28, 2018. Additionally, executive management of the company will be hosting a conference call to discuss the results and provide an operational update on Thursday, November 29, 2018 at 11:00 AM ET. To participate in the conference call, dial 1-800-319-4610 or (604) 638-5340. Following the conclusion of the call, an audio replay will be available for two weeks. To listen to the replay, dial 1-855-669-9658 or (604) 674-8052 and enter the code 2792.

To view the full press release, visit: http://nnw.fm/M6yAB

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Its ability to leverage large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through its strategically positioned cultivation and extraction facilities, Sunniva intends to launch a suite of branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, and extracts while expanding upstream opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, November 26th, 2018 Uncategorized Comments Off on $SNNVF Posting Q3 2018 Results on November 28

$RIV.V Reports Second Quarter Financial Highlights and Provides Corporate Update

TORONTO, Nov. 26, 2018 — Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) today released its financial results for the three and six months ended September 30, 2018. The Company’s full Management’s Discussion and Analysis and unaudited condensed interim consolidated financial statements for the three and six months ended September 30, 2018 are available on SEDAR (www.sedar.com) and posted on the Company’s website at www.canopyrivers.com/financials. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

“The second quarter was highlighted by several key milestones for Canopy Rivers, including the closing of our private placement financing, our go public transaction and listing on the TSX Venture Exchange, our first European investment, and several new developments from our existing portfolio companies,” said Bruce Linton, Chairman and CEO of Canopy Rivers. “With increasingly progressive global sentiment towards cannabis, a rapidly evolving regulatory landscape, and the increased volatility we have observed in the capital markets since legalization, the conditions are there for significant potential gains.  With our strong balance sheet, we believe Canopy Rivers is poised to make highly accretive investments in this robust sector.”

Q2 and Year to Date Fiscal 2019 Financial Highlights:

Select Summary of Quarterly Results (Expressed in Canadian Dollars in Thousands)
As at 30-Sep-18 31-Mar-18
Cash   105,845   46,299
Total Assets   385,168   209,139
Total Liabilities   18,509   16,909
Total Equity   366,659   192,230
Three months ended  30-Sep-18 30-Sep-17
Operating Income   23,273   147
Operating expenses   8,959   2,322
Net operating income (loss)   14,314   (2,175 )
Net income (loss)   10,949   (2,119 )
Other comprehensive income (net of tax)   26,630   –
Total comprehensive income (loss)   37,579   (2,119 )
Basic earnings (loss) per share (“EPS”)   0.08   (0.02 )
Diluted EPS   0.07   (0.02 )
Cash provided by (used in) operating activities   (832 )   (416 )
Cash provided by (used in) investing activities   (13,166 )   (8,699 )
Cash provided by (used in) financing activities   99,705   –
Six months ended  30-Sep-18 30-Sep-17
Operating Income   24,017   147
Operating expenses   16,306   2,896
Net operating income (loss)   7,711   (2,749 )
Net income (loss)   4,321   (2,703 )
Other comprehensive income (net of tax)   24,259   –
Total comprehensive income (loss)   28,580   (2,703 )
Basic earnings (loss) per share (“EPS”)   0.03   (0.04 )
Diluted EPS   0.03   (0.04 )
Cash provided by (used in) operating activities   (1,705 )   219
Cash provided by (used in) investing activities   (39,242 )   (8,719 )
Cash provided by (used in) financing activities   100,493   55,113

“While we are a newly listed public company, we are fortunate to be operating from a position of financial strength,” said Eddie Lucarelli, Chief Financial Officer. “We have a team of technical and financial professionals with years of directly relevant cannabis and investment experience. As we continue to evaluate a pipeline of global opportunities, we remain committed to taking a disciplined approach to investment decisions with long-term value creation in mind. With our pool of capital resources and strategic relationship with the largest cannabis company in the world, Canopy Growth, we believe Canopy Rivers to be well positioned for continued success.”

Q2 Business Highlights:

In a milestone event in the Company’s history, the second quarter was highlighted by the Company’s reverse take-over transaction and listing on the TSX Venture Exchange approximately one month prior to the legalization of adult use cannabis in Canada. The quarter was also highlighted by the closing of the Company’s first international investment in Italy-based Canapar Corp. (“Canapar”). The following is a summary of the Company’s operational milestones for the second quarter:

  • The Company completed an oversubscribed private placement of subscription receipts at $3.50 for gross proceeds of approximately $101 million, co-led by CIBC Capital Markets, GMP Securities L.P. and Eight Capital, and a concurrent non-brokered private placement of subscription receipts for gross proceeds of approximately $3.4 million.  This ultimately led to the go public transaction on September 17, 2018 and the Company began trading on the TSX Venture Exchange under the symbol “RIV” on September 20, 2018.
  • On July 24, 2018, the Company made an investment in equity securities of Canapar of $750,000, representing approximately 35% of the non-diluted common shares of Canapar. Canapar is an organic hemp cultivation, extraction and research & development company based in Italy. This marked the Company’s first investment in Europe, and represents a collaboration with a specialized and well-networked investee headquartered in a strategically located region with a rich agricultural history. Canapar is focused on developing and commercializing Italy’s local hemp cultivation industry through an outsource farming model, supporting farmers with continuing education and establishment of organic cannabis cultivation. Canapar intends to purchase hemp on a wholesale basis from farmers and extract organic cannabidiol (“CBD”) oil from the hemp. The Company and Canapar have been working closely together in advancing Canapar’s post-harvest processing of hemp and extraction capabilities. Canapar further benefits from a strategic relationship with the Department of Agriculture at the University of Catania, which carries out significant research regarding agricultural and food production, including hemp-based cultivation and extraction methodology.
  • During the second quarter of fiscal 2019, the Company further bolstered its team with the addition of Narbe Alexandrian as its VP, Business Development. Previously with OMERS Ventures, Alexandrian brings a depth of venture capital experience, specifically in the software and technology sectors.

Portfolio Update:

To date, the Company has made investments in eleven companies, and in doing so has established a diversified portfolio of investments including licensed companies, late stage licence applicants, international hemp cultivators, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. The following is an update of selected recent activity of the portfolio companies not already discussed above. For more information regarding the Company’s portfolio investments, please refer to the Management’s Discussion and Analysis of Financial Results for the three and six months ended September 30, 2018 (“MD&A”), filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

  • PharmHouse Inc. (“PharmHouse”) is a joint venture between Canopy Rivers and the principals and operators of a leading North American greenhouse produce conglomerate with specialized agricultural, production, contract manufacturing, branding, distribution, and logistics experience. PharmHouse will operate out of 1.3 million square feet of newly constructed modern greenhouse infrastructure in Leamington, Ontario with the intent of becoming a licensed producer of high-quality greenhouse grown cannabis. Subsequent to the end of the quarter, PharmHouse secured an offtake agreement with fellow Canopy Rivers portfolio company TerrAscend Corp. for 20% of the flowering space at its greenhouse facility until December 31, 2021. PharmHouse also entered into an incremental funding agreement and amended its global non-competition agreement with the Company to include the U.S. cannabis market. The Company will provide up to $40 million of secured debt financing with a three-year term and an annual interest rate of 12%, calculated monthly and payable quarterly after receipt of the sales license at PharmHouse’s initial production and processing facility. Proceeds are expected to be utilized to supplement personnel and logistics resources for domestic and international distribution, capital expenditures related to the ongoing upgrade and retrofit of PharmHouse’s nursery, processing, and greenhouse infrastructure, working capital, and other general corporate purposes.
  • TerrAscend Corp. (“TerrAscend”) (CSE: TER) is a biopharmaceutical and wellness company providing quality products, brands and services for the global cannabinoid market. TerrAscend has secured supply agreements with the provinces of Ontario, British Columbia, Nova Scotia and PEI and launched a premium cannabis brand, Haven Street, for the Canadian adult-use market. Subsequent to end of the quarter, the Company entered into an arrangement agreement to restructure its investment in TerrAscend to accommodate and obtain exposure to TerrAscend’s plans to leverage its Canadian Securities Exchange listing and U.S. specialty pharmaceutical and finance relationship networks to explore and pursue growth opportunities in the U.S. and other regulated jurisdictions. If the plan of arrangement is approved, the Company will exchange its common shares of TerrAscend for new, non-participating, non-voting conditionally exchangeable shares in the capital of TerrAscend. These new exchangeable shares may only be converted into common shares of TerrAscend upon certain changes in U.S. federal laws or regulatory approaches regarding the cultivation, distribution or possession of cannabis in the U.S., the compliance of TerrAscend with such laws, and the approval of the various securities exchanges. In agreeing to restructure its TerrAscend investment and to remain in compliance with all public exchanges and regulators, the Company opted to trade short-term liquidity for what the Company believes will be significant long-term value.  Also subsequent to the end of the quarter, TerrAscend secured an offtake arrangement for 20% of flowering space at PharmHouse’s greenhouse facility. The agreement will supply dried flower and trim for packaging, processing and distribution throughout the TerrAscend logistics platform.
  • Radicle Medical Marijuana Inc. (“Radicle”) is a licensed cultivator producing premium indoor small-batch cannabis that is hydroponically grown and processed with a craft methodology and proprietary dry, trim and cure processes. Radicle was one of twenty-six licensed cannabis producers selected by the Ontario Cannabis Store in a highly competitive product call for recreational sale online and one of two entities selected despite only having a licence to cultivate at the time. Subsequent to the end of the second quarter of fiscal 2019, Radicle received its production and sales licence from Health Canada. The receipt of the sales license, for oil and dried flower, was also a milestone event for the Company, as it triggered the conversion of the Company’s outstanding debenture with Radicle into an almost 24% equity stake in Radicle, and set-off against consideration otherwise paid for a royalty interest with a minimum yearly guarantee of $900,000 for the next 20 years.  Radicle also recently announced the launch of Gage Cannabis Co., a new brand that offers high-grade craft cannabis through proprietary and sustainable growth methods.
  • Les Serres Vert Cannabis Inc. (“Vert Mirabel”), is a joint venture with Canopy Growth and Les Serres Stéphane Bertrand, and is based in Mirabel, Quebec.  The greenhouse property has been upgraded and retrofitted, and recently received a licence amendment from Health Canada increasing the greenhouse production footprint from 40,000 to 525,000 square feet licensed operating space available for cannabis production. Vert Mirabel will be a key source of locally-produced cannabis products for the government of Quebec and Canopy Growth has secured a significant supply agreement with the Société des alcools du Québec (SAQ). The greenhouse is organic certified, a value-add differentiator in cannabis brands, and the intent will be to apply the infrastructure and farming expertise to grow organic cannabis flower.
  • Agripharm Corp. (“Agripharm”) is a licensed company under the Cannabis Act, and is a joint venture between Canopy Growth and the owners of globally-recognized cannabis brands Green House Seeds (a Netherlands-based portfolio of leading cannabis businesses, including an award-winning genetics portfolio, and pioneer in the development of the European cannabis coffee shop market) and Organa Brands (owner of several market-leading cannabis brands, including OpenVAPE, Bakked, Organa Labs, The Magic Buzz, and District Edibles). Agripharm is building out its extraction capacity, leveraging the experience of their joint venture partner Organa Brands Ltd., a long-standing cannabis extract product innovator in the U.S., to be well-positioned when Canadian regulations allow for new product formats. The indoor growing facility continues to focus on the phenotyping of new strains and benefits from their relationship with Green House Seeds.
  • James E. Wagner Cultivation Ltd. (“JWC”) (TSXV: JWCA) is a licensed cultivator focusing on producing clean, consistent cannabis. In August, JWC received its licence approval from Health Canada for the production of formulated cannabis oil. In addition to its already available aeroponically-grown dried flower products, JWC intends to develop and supply cannabis oil products in varying content and size configurations in anticipation of patient and customer demands. Subsequent to the end of the second quarter of fiscal 2019, product from JWC was added to the SpectrumCannabis.com online marketplace through their participation in Canopy Growth’s CraftGrow program. JWC is also expanding into a second facility, which is designed to provide a total of approximately 345,000 square feet of cultivation space.
  • Civilized Worldwide Inc. (“Civilized”) is an international modern media company and lifestyle brand focused on elevating cannabis culture. Civilized has a premium digital audience throughout North America and has established an events platform where individuals and industry can communicate and work together to evolve the global perception of cannabis. The Company made an investment in Civilized on April 17, 2018 by means of a convertible debenture and also received warrants to purchase class A common shares of Civilized. In June 2018, Civilized hosted the inaugural World Cannabis Congress in Saint John, New Brunswick, with the goal of promoting conversations that shape and advance the cannabis industry worldwide. Civilized also partnered with comedian Chelsea Handler for a nation-wide speaking tour covering political activism, culture and cannabis.
  • Spot Therapeutics Inc. (“Spot”) is a large-scale indoor production and distribution facility located in Fredericton, New Brunswick. The Company is funding the ongoing capital expenditures related to the build-out of the asset in exchange for a long-term royalty and lease obligation. Construction on the retrofit of the facility is complete, and a readiness package has been submitted to Health Canada as part of the licensing process.
  • LiveWell Canada Inc. (“LiveWell”) (TSXV: LVWL) is a Canadian hemp and cannabis company focused on advanced research of CBD and other cannabinoids, as well as developing and distributing prescription and consumer health and wellness products. Effective April 2, 2018, the Company executed a strategic agreement to accelerate the development and commercialization of LiveWell’s two large-scale projects for future cannabis production and processing. The Company received an equity interest, representing 5% of the issued and outstanding common shares of LiveWell on a fully-diluted basis, in exchange for strategic support from the Company. On June 17, 2018, LiveWell completed its go public transaction and began trading on the TSX Venture Exchange on June 21, 2018. LiveWell recently secured 1,000 acres of Canadian industrial hemp for the purpose of extracting and producing CBD-based products for distribution in Canada. Subsequent to the end of the second quarter of fiscal 2019, LiveWell entered into an agreement to acquire 100% of Acenzia Inc., a Health Canada and GMP-certified developer and manufacturer of natural health products and therapeutics. These capabilities are intended to further develop LiveWell’s focus on health-related research in cannabis and hemp, as well as fast-track its product development at a lower cost.
  • Aldershot Resources Ltd. d.b.a. Solo Growth Corp.™ (“Solo”) is executing on a retail-focused cannabis strategy with store locations branded as “YSS by Solo” led by the principals of Solo Liquor Stores Ltd., a leading Canadian private liquor retailer. The Solo team has been effective in capturing significant liquor market share in the communities they operate by providing a shopping experience and product offering that is customized to each location’s demands. Solo also has a strong understanding of and access to commercial real estate. In Alberta, Solo has 25 license applications pending with the Alberta Gaming, Liquor and Cannabis Commission for retail locations. Solo expects to have 3 to 5 cannabis stores constructed by the end of the year. In Ontario, Canada’s largest provincial cannabis market, Solo has secured 32 leases and has the opportunity to open a maximum of 75 locations.

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions; the global sentiment towards cannabis; evolution of the regulatory landscape; conditions for potential gains; market volatility; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in the Company’s relationship with Canopy Growth; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the the joint management information circular of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: 

Canopy Rivers Inc.
www.canopyrivers.com

Karoline Hunter
Sr. Director, Investor Relations & Communications
E-mail: ir@canopyrivers.com

Daniel Pearlstein
Executive Vice President, Strategy
E-mail: daniel@canopyrivers.com

Monday, November 26th, 2018 Uncategorized Comments Off on $RIV.V Reports Second Quarter Financial Highlights and Provides Corporate Update

$PFSF Blockchain eCommerce Platform Enables Trade between Asian and Latin American Giants

  • China is Brazil’s largest trading partner
  • Chinese President Xi Jinping promoted trade relations at China International Import Expo on November 5-10
  • eCommerce platforms like Pacific Software’s Agri-Blockchain expected to boost trade

Trade between Brazil and China, the largest countries in South America and Asia, looks set to increase further after the recently concluded import fair put on by the Chinese authorities. The gravity of the trade initiative was marked by the presence of President Xi Jinping, who gave the opening address to the exhibitors gathered at the National Convention & Exhibition Center in Shanghai, China. The China International Import Expo (CIIE) ran for six days, November 5-10, in China’s largest city. The official word is that Brazilian exporters will have better access to Chinese markets through platforms like Alibaba.com and Tmall.com, highlighting the importance of such technologies. Given its capability to provide a highly effective trust mechanism that can track complex transactions using cryptographically secure Hyperledger Blockchain technology, the proprietary e-commerce trade platform under development by Pacific Software, Inc. (OTC: PFSF) could also play a role in boosting trade between the Asian and Latin American giants.

Many barriers separate Brazil from China. The metaphorical crow must cross two continents – Africa and Europe – if it embarks on a flight path from Brazilia to Beijing. With a time difference of…

Read more »

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, November 21st, 2018 Uncategorized Comments Off on $PFSF Blockchain eCommerce Platform Enables Trade between Asian and Latin American Giants

$DPW CEO and Chairman to Present at the LD Micro Main Event

Diversified holding company DPW Holdings (NYSE American: DPW) this morning announced that its CEO and Chairman, Milton “Todd” Ault, III will be presenting at the 11th Annual LD Micro Main Event on December 4, 2018 at 5 PM ET. Joining Ault, DPW Holdings CAO Kenneth S. Cragun and CEO of Digital Power Lending William “Billy” Corbett will be available for one-on-one meetings throughout the day. The event, which is anticipated to be attended by more than 1,200 individuals, will be held in Los Angeles at the Luxe Sunset Bel Air Hotel December 4 – 6, 2018, and is expected to feature 250 companies. A live webcast of DPW’s presentation will be available on the company’s website, and a replay will be available for 90 days.

To view the full press release, visit: http://nnw.fm/6JtKq

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with global impact. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. For more information, visit the company’s website at www.DPWHoldings.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, November 21st, 2018 Uncategorized Comments Off on $DPW CEO and Chairman to Present at the LD Micro Main Event

$SNNVF to Announce 2018 Third Quarter Results on November 28, 2018

VANCOUVER, British Columbia, Nov. 21, 2018 — Sunniva Inc. (“Sunniva” or the “Company”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, plans to release its results for the third quarter 2018, after market close on Wednesday, November 28, 2018.

The Company’s executive management will discuss the results and provide an operational update during a conference call on Thursday, November 29, 2018 at 11:00 am Eastern Time / 8:00 am Pacific Time.  To participate in the call please dial 1-800-319-4610, or (604) 638-5340.  An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674-8052 and entering code 2792.  The replay will be available for two weeks following the call.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California.  Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including premium concentrates, vape cartridges, flower, pre-rolls, and beverages as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Contact: 
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com
Media Contact:
Katelyn Tumino
KCSA Strategic Communications
Phone: (212) 896-1252
Email: ktumino@kcsa.com
Wednesday, November 21st, 2018 Uncategorized Comments Off on $SNNVF to Announce 2018 Third Quarter Results on November 28, 2018

$YGYI Market Trends Toward New Normal, Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Nov. 21, 2018 – In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TRNS DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRNS
BTAI DOWNLOAD: http://Fundamental-Markets.com/register/?so=BTAI
YGYI DOWNLOAD: http://Fundamental-Markets.com/register/?so=YGYI
AQST DOWNLOAD: http://Fundamental-Markets.com/register/?so=AQST
TRMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRMD
TGA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

—————————————–

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

—————————————–

TRANSCAT, INC. (TRNS) REPORT OVERVIEW

Transcat’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transcat reported revenue of $38.88MM vs $35.93MM (up 8.22%) and analysts estimated basic earnings per share $0.21 vs $0.11 (up 90.91%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Transcat reported revenue of $155.14MM vs $143.90MM (up 7.81%) and analysts estimated basic earnings per share $0.83 vs $0.65 (up 27.69%). Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.13 and is expected to report on May 28th, 2019.

To read the full Transcat, Inc. (TRNS) report, download it here: http://Fundamental-Markets.com/register/?so=TRNS

—————————————–

BIOXCEL THERAPEUTICS, INC. (BTAI) REPORT OVERVIEW

BioXcel Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$1.94 and is expected to report on February 8th, 2019.

To read the full BioXcel Therapeutics, Inc. (BTAI) report, download it here: http://Fundamental-Markets.com/register/?so=BTAI

—————————————–

YOUNGEVITY INTERNATIONAL INC. (YGYI) REPORT OVERVIEW

Youngevity International’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Youngevity International reported revenue of $39.08MM vs $44.40MM (down 11.97%) and analysts estimated basic earnings per share -$0.46 vs -$0.05. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Youngevity International reported revenue of $165.70MM vs $162.67MM (up 1.86%) and analysts estimated basic earnings per share -$0.65 vs -$0.02. Analysts expect earnings to be released on April 4th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Youngevity International Inc. (YGYI) report, download it here: http://Fundamental-Markets.com/register/?so=YGYI

—————————————–

AQUESTIVE THERAPEUTICS, INC. (AQST) REPORT OVERVIEW

Aquestive Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$0.99 and is expected to report on February 5th, 2019.

To read the full Aquestive Therapeutics, Inc. (AQST) report, download it here: http://Fundamental-Markets.com/register/?so=AQST

—————————————–

TORM PLC (TRMD) REPORT OVERVIEW

TORM’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, TORM reported revenue of $140.40MM vs $155.80MM (down 9.88%) and analysts estimated basic earnings per share -$0.34 vs -$0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TORM reported revenue of $656.99MM vs $680.14MM (down 3.40%) and analysts estimated basic earnings per share $0.04 vs -$2.30. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full TORM PLC (TRMD) report, download it here: http://Fundamental-Markets.com/register/?so=TRMD

—————————————–

TRANSGLOBE ENERGY CORP (TGA) REPORT OVERVIEW

Transglobe Energy’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transglobe Energy reported revenue of $42.63MM vs $44.85MM (down 4.95%) and analysts estimated basic earnings per share -$0.17 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Transglobe Energy reported revenue of $148.57MM vs $63.81MM (up 132.85%) and analysts estimated basic earnings per share -$1.09 vs -$1.21. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08.

To read the full Transglobe Energy Corp (TGA) report, download it here: http://Fundamental-Markets.com/register/?so=TGA

—————————————–

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Wednesday, November 21st, 2018 Uncategorized Comments Off on $YGYI Market Trends Toward New Normal, Emerging Consolidated Expectations, Analyst Ratings

$TGODF Cannabis Industry Growth Spurred by Rising Medicinal Applications for Health Issues

Palm Beach, FL – (November 20, 2018) — The medicinal uses niche of the cannabis industry continues to generate strong revenues as consumers are searching for alternative treatments and natural solutions for various health issues and conditions. Cannabis and CBD-based medicines and treatments have emerged at a key point in the evolution of the healthcare sector and leaders are capitalizing on momentum through the development of new products and marketing to new customer bases. It’s widely known that a billion dollar valuation for the medical cannabis market is a matter of when as opposed to it as the growth continues to accelerate with competition as well as innovation and favorable political conditions influence the landscape. Active companies in the industry making moves to ready that include:  Choom™ Holdings Inc. (CSE:CHOO) (OTC:CHOOF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), MedMen Enterprises Inc. (CSE:MMEN.CN) (OTC:MMNFF), HEXO Corp. (TSX:HEXO) (OTC:HYYDF).

Choom™ Holdings Inc.  (CSE: CHOO) (OTCQB: CHOOF) BREAKING NEWS:  Choom™, an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.

Chris Bogart, President & CEO states, “Our goal is to build a dominant national cannabis retail brand. The acquisition of Clarity Medical Centres allows Choom to service the entire Canadian cannabis market, beyond just the adult use channel. As cannabis becomes more widely accepted as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the benefits and best use of cannabis as a treatment.”

The acquisition includes five new medical centres along with a proprietary telemedicine platform that provides important education, access and expertise for referring patients in the use of cannabis for medical purposes. The Clarity Medical Centres approach makes it simple for new patients to access legal medical cannabis products in Canada and streamlines the process of registering with a licensed producer.

 

There are medical conditions that may benefit from cannabis when it comes to treating several health issues including chronic pain, PTSD, seizures, tremors, and general anxiety. Clarity’s team of cannabis trained general and specialist physicians, nurses, pharmacists, and coaches all work together to ensure patients get optimal medical care. The clinics will provide education to patients on the best use of medical cannabis products as an alternative to pharmaceuticals.

Under the leadership of Dr. Jean Paul Lim, an internal medicine and complex care specialist, Clarity Medical Centres intend to study and monitor the effects of medicinal cannabis use. Clarity Medical Centres will use a patient-focused, research-based, multidisciplinary approach, from which Dr. Lim hopes to shatter cannabis misconceptions and build scientific evidence through the collection of patient data points around cannabis as an effective treatment.

As part of the transaction, Choom can access medical expertise from the clinics and leverage key learnings from the medical side to provide customer insights for our adult use channel. The Clarity medical clinic model is easily scalable and transferable across the rapidly growing medical cannabis space, both domestically and internationally adding an important retail revenue stream to Choom’s adult use strategy.   Read this and more news for Choom™ at:     https://www.financialnewsmedia.com/news-choo/

Additional industry related developments from around the markets:

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB.TO) last week announced the appointment of Dr. Jonathan Page, PhD as the Company’s Chief Science Officer. In this new role, Dr. Page will oversee all science-related projects at the Company. The Aurora science team develops innovative products for the medical, wellness and adult consumer markets and focuses on delivering industry-leading cultivation results in terms of yields, consistency, quality and efficiency. Dr. Page is a globally renowned cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome. His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr. Page served as CEO of recently acquired Anandia Labs, the world-leading cannabis-focused science company he co-founded. “We are thrilled to have Jonathan join the Aurora team as Chief Science Officer,” said CEO Terry Booth. “Jonathan’s knowledge of the cannabis plant and its applications make him a globally recognized leader in the cannabis sector.

MedMen Enterprises Inc. (CSE:MMEN.CN) (OTCQX:MMNFF) recently announced that, further to its press release dated November 16, 2018 , the Company has been issued a receipt by the applicable Canadian securities regulatory authorities for its preliminary prospectus dated November 16, 2018 (the “Preliminary Prospectus”) in connection with its offering of 13,640,000 units (“Units”), at a price per Unit of $5.50 , for gross proceeds of $75,020,000 , to be issued and sold on a bought deal basis to a syndicate of underwriters, led by Canaccord Genuity Corp., and including Eight Capital and Cormark Securities Inc. (the “Offering”). Each Unit will be comprised of one Class B Subordinate Voting Share of the Company (each, a “Class B Share”) and one Class B Share purchase warrant (each, a “Warrant”). Each Warrant will be exercisable at a price of $6.87 per Class B Share for a term expiring on September 27, 2021. For further details, please refer to the Preliminary Prospectus and the Company’s press release dated November 16, 2018.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) last week announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada . Velvet is a new company with distinct ownership created by the largest wine distributor in Canada , Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

HEXO Corp. (TSX:HEXO.TO) (OTCPK:HYYDF) recently announced the closing of the acquisition of its interest in a large facility in Belleville, Ontario. This is the first facility that the Company has established outside of Quebec, further delivering on its national expansion strategy and allowing HEXO to create a centre of excellence for the development of advanced cannabis products. “Closing the transaction and acquiring our interest in this facility is integral to carrying out our hub and spoke business strategy,” said Sebastien St-Louis, HEXO’s CEO and co-founder. “The space can be scaled up based on our future needs and provides HEXO with the infrastructure it needs to continue partnering with Fortune 500 companies and to create category-winning cosmetics, edibles, vapes and more.” The centralized location, conveniently located along primary shipping routes in Ontario, will allow HEXO to process and distribute cannabis-based products to fulfil its commitments across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email:  editor@financialnewsmedia.com – +1(561)325-8757

Tuesday, November 20th, 2018 Uncategorized Comments Off on $TGODF Cannabis Industry Growth Spurred by Rising Medicinal Applications for Health Issues